Information Provided By: 
Fly News Breaks for April 4, 2019
NTRA
Apr 4, 2019 | 07:47 EDT
Baird analyst Catherine Ramsey Schulte maintained an Outperform rating and $24 price target on Natera, saying she continues to recommend Natera as a top idea following recent investor meetings with CEO Steve Chapman and CFO Mike Brophy. The analyst thinks Natera's core business is healthy and believes transplant and oncology opportunities are only partially valued in the stock today and could drive meaningful upside over the next few years.
News For NTRA From the Last 2 Days
There are no results for your query NTRA
